CaRe Clinic Joins hyperCORE International to Strengthen Global Clinical Research Capabilities
TL;DR
Joining hyperCORE International gives CaRe Clinic a competitive advantage in expanding global reach and capabilities through alliance partnerships.
CaRe Clinic's community-centric recruitment strategy, state-of-the-art research centers, and strong partnerships contribute to its success in redefining medical research in Canada.
CaRe Clinic's partnership with hyperCORE International aims to pioneer breakthroughs that will benefit patients worldwide, highlighting Canada's robust clinical research ecosystem on the global stage.
CaRe Clinic's broad combination of investigators' patient databases and access to a reservoir of over 1.8 million potential patients makes it a key player in advancing clinical research.
Found this article helpful?
Share it with your network and spread the knowledge!
CaRe Clinic, a prominent multi-specialty research organization based in Alberta, Canada, has joined the collaborative super network of hyperCORE International, marking a significant expansion of global clinical trial capabilities. This strategic alliance brings together CaRe Clinic's two state-of-the-art research centers serving Calgary and Red Deer with hyperCORE's extensive international network, creating enhanced opportunities for clinical research advancement across multiple therapeutic areas.
The organization's extensive patient database, developed through investigator databases and strong partnerships with affiliated clinics, provides access to a potential patient pool of over 1.8 million individuals. This vast resource, combined with CaRe Clinic's community-centric recruitment strategy, offers unparalleled participant recruitment capabilities across various medical indications including women's health, dermatology, general medicine, vaccines, infectious diseases, and migraine treatments. Troy Hamilton, Director of Operations at CaRe Clinic, emphasized the partnership's significance for global research collaboration and best practice sharing.
hyperCORE International, already an industry leader in providing Phase I-IV clinical trial services, now expands its presence in Canada with multiple locations and a multi-therapeutic offering. The organization's global footprint now spans two continents and five countries, with more than 120 active research sites. Carlos Orantes, President of hyperCORE and CEO at alliance partner Alcanza Clinical Research, expressed enthusiasm about the immediate expansion of hyperCORE's Canadian footprint and the addition of a solid partner to the team.
The collaboration leverages hyperCORE International's decades of clinical research experience, with alliance partners having completed more than 7,000 studies and evaluated thousands of new drugs and treatments in over 150,000 randomized patients. The organization is recognized for its commitment to research excellence, prioritizing subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention. This partnership is expected to accelerate clinical research and drug development pace, potentially leading to faster medical treatment breakthroughs across therapeutic areas.
By combining CaRe Clinic's robust patient database and recruitment capabilities with hyperCORE's extensive experience and global network, the alliance addresses critical challenges in clinical trials such as patient recruitment and retention. For the broader medical and pharmaceutical industries, this collaboration represents a trend toward more integrated, efficient, and globally connected clinical research networks, emphasizing international cooperation's importance in advancing medical science and bringing new treatments to patients worldwide more rapidly and effectively.
Curated from 24-7 Press Release
